The earth BioGenome project 2020: Starting the clock HA Lewin, S Richards, E Lieberman Aiden, ML Allende, JM Archibald, ... Proceedings of the National Academy of Sciences 119 (4), e2115635118, 2022 | 173 | 2022 |
What If Extinction Is Not Forever? JS Sherkow, HT Greely Science 340 (6128), 32-33, 2013 | 167 | 2013 |
CRISPR, Surrogate Licensing, and Scientific Discovery JL Contreras, JS Sherkow Science 355 (6326), 698-700, 2017 | 81 | 2017 |
The History of the Patenting of Genetic Material JS Sherkow, HT Greely Annual Review of Genetics 49 (1), 161-182, 2015 | 77 | 2015 |
Patent Law's Reproducibility Paradox JS Sherkow Duke Law Journal 66, 845-911, 2017 | 62 | 2017 |
Inferred Allelic Variants of Immunoglobulin Receptor Genes: A System for their Evaluation, Documentation and Naming M Ohlin, C Scheepers, M Corcoran, WD Lees, CE Busse, D Bagnara, ... Frontiers in immunology 10, 435, 2019 | 58 | 2019 |
The Natural Complexity of Patent Eligibility JS Sherkow Iowa Law Review 99, 1137-1196, 2014 | 52 | 2014 |
Law, History and Lessons in the CRISPR Patent Conflict JS Sherkow Nature Biotechnology 33 (3), 256-257, 2015 | 50 | 2015 |
23andMe, the Food and Drug Administration, and the Future of Genetic Testing PJ Zettler, JS Sherkow, HT Greely JAMA Internal Medicine 174 (4), 493-494, 2014 | 50 | 2014 |
Differential Requirements for MCM Proteins in DNA Replication in Drosophila S2 Cells G Crevel, R Hashimoto, S Vass, J Sherkow, M Yamaguchi, MMS Heck, ... PLoS One 2 (9), e833, 2007 | 48 | 2007 |
The Rise of the Ethical License CJ Guerrini, MA Curnutte, JS Sherkow, CT Scott Nature Biotechnology 35 (1), 22-24, 2017 | 47 | 2017 |
The CRISPR Patent Landscape: Past, Present, and Future JS Sherkow The CRISPR journal 1 (1), 5-9, 2018 | 44 | 2018 |
Patent Protection for CRISPR: An ELSI Review JS Sherkow Journal of Law and the Biosciences 4 (3), 565-576, 2017 | 44 | 2017 |
Administrating Patent Litigation JS Sherkow Washington Law Review 90, 205-269, 2015 | 41 | 2015 |
Regulating Genetic Biohacking PJ Zettler, CJ Guerrini, JS Sherkow Science 365 (6448), 34-36, 2019 | 40 | 2019 |
CRISPR, Patents, and the Public Health JS Sherkow Yale Journal of Biology and Medicine 90 (4), 667–672, 2017 | 35 | 2017 |
Negativing Invention JS Sherkow BYU Law Review 2011 (4), 1091-1138, 2011 | 35 | 2011 |
Pursuit of Profit Poisons Collaboration JS Sherkow Nature 532, 172-173, 2016 | 33 | 2016 |
Biological Controls for Standardization and Interpretation of Adaptive Immune Receptor Repertoire Profiling J Trück, A Eugster, P Barennes, CM Tipton, ETL Prak, D Bagnara, C Soto, ... eLife 10, e66274, 2021 | 29 | 2021 |
Cancer's IP JS Sherkow North Carolina Law Review 96, 297-380, 2017 | 29 | 2017 |